Literature DB >> 8771516

Clinical optokinetic nystagmus asymmetry in treated esotropes.

K W Wright1.   

Abstract

BACKGROUND: Monocular optokinetic nystagmus (OKN) asymmetry is associated with disruption of early binocular visual development.
METHODS: Three groups of treated esotropic patients and a group of normal controls were evaluated for the presence of clinically detectable monocular OKN asymmetry. Clinical assessment of monocular OKN asymmetry was performed by observing eye movements in response to a hand-held rotating drum. Asymmetry was quantitated on a scale of 0 to +3 OKN asymmetry. Clinical OKN asymmetry was evaluated in the following groups of patients: those with congenital esotropia treated with very early surgery achieving high-grade stereo acuity (group 1); those with congenital esotropia treated with late surgery achieving no stereopsis (group 2); those with acquired esotropia achieving high-grade stereo acuity after treatment with spectacle correction (group 3); and normal controls (group 4).
RESULTS: Two of the three patients in group 1 showed +3 OKN asymmetry despite having high-grade stereo acuity; the third one, who was surgically aligned earliest (13 weeks), demonstrated +1 OKN asymmetry. This patient achieved orthotropia, 40 seconds stereo acuity, perfect Randot stereo acuity, and had no dissociated vertical deviation or latent nystagmus. All 10 patients in group 2 (those with late alignment-after 1 year-and no stereo acuity) showed +3 OKN asymmetry. All four patients in group 3 (those with acquired hypermetropic esotropia and high-grade stereo acuity after treatment) and all 10 patients in the normal control group showed no OKN asymmetry.
CONCLUSION: Clinically obvious monocular OKN asymmetry can occur in patients with congenital esotropia who are aligned early and develop high-grade stereo acuity. Even brief periods of strabismus during the early period of binocular motor development can result in persistent OKN asymmetry. This suggests that binocular motor processing may develop distinct from, and prior to, the development of high-grade stereo acuity. OKN asymmetry appears to be a clinical sign of an insult to early binocular motor development.

Entities:  

Mesh:

Year:  1996        PMID: 8771516     DOI: 10.3928/0191-3913-19960501-06

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  7 in total

1.  Effect of binocular rivalry suppression on initial ocular following responses.

Authors:  Mingxia Zhu; Richard W Hertle; Chang H Kim; Xuefeng Shi; Dongsheng Yang
Journal:  J Vis       Date:  2008-04-23       Impact factor: 2.240

2.  Quadrantal macular retinal thickness changes in strabismus subjects with abnormal binocular vision development.

Authors:  Mayumi Oka; Tsutomu Yamashita; Shizuka Ono; Ikumi Kubo; Akio Tabuchi
Journal:  Jpn J Ophthalmol       Date:  2012-11-28       Impact factor: 2.447

3.  An Optokinetic Nystagmus Detection Method for Use With Young Children.

Authors:  Mehrdad Sangi; Benjamin Thompson; Jason Turuwhenua
Journal:  IEEE J Transl Eng Health Med       Date:  2015-03-05       Impact factor: 3.316

4.  Duration of binocular decorrelation in infancy predicts the severity of nasotemporal pursuit asymmetries in strabismic macaque monkeys.

Authors:  A Hasany; A Wong; P Foeller; D Bradley; L Tychsen
Journal:  Neuroscience       Date:  2008-07-25       Impact factor: 3.590

5.  Vergence nystagmus induced by motion in the ground plane: normal response characteristics.

Authors:  Dongsheng Yang; Mingxia Zhu; Chang H Kim; Richard W Hertle
Journal:  Vision Res       Date:  2007-03-23       Impact factor: 1.886

Review 6.  Timing of surgery for infantile esotropia: sensory and motor outcomes.

Authors:  Agnes M F Wong
Journal:  Can J Ophthalmol       Date:  2008-12       Impact factor: 1.882

7.  A Fast and Effective System for Analysis of Optokinetic Waveforms with a Low-Cost Eye Tracking Device.

Authors:  Chong-Bin Tsai; Wei-Yu Hung; Wei-Yen Hsu
Journal:  Healthcare (Basel)       Date:  2020-12-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.